ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Nufactor® Receives URAC’s Full Certification as a Rare Disease Pharmacy Center of Excellence

TEMECULA, Calif., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Nufactor, Inc., a specialty infusion company and subsidiary of FFF Enterprises, Inc., is delighted to announce that it has received full certification as a Rare Disease Pharmacy Center of Excellence by the Utilization Review Accreditation Commission (URAC). This award is effective from September 1, 2024 to March 1, 2027.

Having previously been awarded the Pioneer in Performance Measurement by URAC in 2021 and 2022, this marks the third time that Nufactor has received a prestigious certification from the nation’s foremost independent health care accreditation organization. URAC is the independent leader in promoting health care quality by setting high standards for clinical practice, consumer protections, performance measurement, operations infrastructure and risk management. By achieving this status, Nufactor has demonstrated its commitment to quality care, enhanced processes, patient safety and improved outcomes.

“Nufactor is honored to receive URAC’s certification as a Rare Disease Pharmacy Center of Excellence. We’re proud to be known and awarded for the high level of care we provide to patients with rare diseases. This is an exceptional distinction,” says Joe DiStefano, RPh, IgCP®, CSP, vice president, clinical programs. “This continued recognition highlights Nufactor’s dedication to excellence in patient care and access, illustrating our alignment with URAC’s enduring mission: ‘exceptional healthcare for all.’”

URAC’s Rare Disease Certification demonstrates that Nufactor goes above and beyond when treating patients with rare diseases, and URAC describes this unique certification as, “developed with the input of rare disease experts, including NORD — The National Organization for Rare Disorders — to ensure it reflects current and proven best practices.”

“Patient care is at the heart of what URAC-accredited organizations do and we are proud to recognize Nufactor for achieving the Rare Disease Pharmacy Center of Excellence Certification,” said URAC President and CEO, Shawn Griffin, MD. “This certification reflects Nufactor’s commitment to their high quality in health care in the areas of risk management, consumer protection and empowerment, operations and infrastructure, as well as performance management and improvement.”

About Nufactor, Inc.
Nufactor, Inc. is a specialty infusion company and subsidiary of FFF Enterprises, Inc., the largest and most trusted specialty pharmaceutical distributor and diversified healthcare organization. Established in 1995, Nufactor offers safe, convenient, and reliable home infusion solutions for patients receiving immunoglobulin, plasminogen, antihemophilic factor, and infliximab. Nufactor has earned The Joint Commission’s Gold Seal of Approval® and URAC’s Specialty Pharmacy Accreditation. Please visit LinkedIn, Instagram, Facebook, and YouTube for more information about the company.

About FFF Enterprises, Inc.
Founded in 1988, FFF Enterprises, Inc. is a privately held, multibillion-dollar specialty pharmaceutical distributor and diversified healthcare organization. FFF Enterprises is the parent company to leading specialty infusion company Nufactor, Inc., as well as InCircle, LLC and RightNow Inventory™. Our partners include global pharmaceutical and biologics manufacturers, prestigious healthcare systems, large and independent retail pharmacies, and leading alternate care sites. Our nationwide commerce is supported by a network of distribution and infusion pharmacy locations utilizing world-class technology and cybersecurity solutions. Please visit FFF Enterprises’ news site, as well as LinkedIn, X, Facebook, Instagram, and YouTube for more information about the company.

About URAC
Founded in 1990 as a non-profit organization, URAC is the independent leader in promoting health care quality and patient safety through renowned accreditation programs. URAC develops its evidence-based standards in collaboration with a wide array of stakeholders and industry experts. The company’s portfolio of accreditation and certification programs span the health care industry, addressing health care management and operations, pharmacies, telehealth, health plans, medical practices and more. URAC accreditation is a symbol of excellence for organizations to showcase their validated commitment to quality and accountability. Learn more at www.urac.org.

Attachment


Michelle Valenzuela
FFF Enterprises.com
(951) 296-2528 ext 1410
mvalenzuela@fffenterprises.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.69
+3.55 (1.63%)
AAPL  271.49
+5.24 (1.97%)
AMD  203.78
-2.24 (-1.09%)
BAC  51.56
+0.56 (1.10%)
GOOG  299.65
+9.67 (3.33%)
META  594.25
+5.10 (0.87%)
MSFT  472.12
-6.31 (-1.32%)
NVDA  178.88
-1.76 (-0.97%)
ORCL  198.76
-11.93 (-5.66%)
TSLA  391.09
-4.14 (-1.05%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.